Decrease in vaccination rates in AZ schools; New skin cancer treatment; remembering Harry Mitchell
Season 2026 Episode 159 | 22m 15sVideo has Closed Captions
Infants receive fewer immunizations; Phoenix has new therapy for melanoma; Harry Mitchell passes
President signed an executive order on Monday that infants should receive fewer immunizations, at a time when a new report shows most Arizona classrooms do not have a high enough vaccination rates to prevent an outbreak of measles; Banner MD Anderson in Phoenix is now offering a groundbreaking therapy for melanoma patients; Harry Mitchell, a former Tempe mayor and U.S. congressman, has died at 86
Problems playing video? | Closed Captioning Feedback
Problems playing video? | Closed Captioning Feedback
Arizona Horizon is a local public television program presented by Arizona PBS
Decrease in vaccination rates in AZ schools; New skin cancer treatment; remembering Harry Mitchell
Season 2026 Episode 159 | 22m 15sVideo has Closed Captions
President signed an executive order on Monday that infants should receive fewer immunizations, at a time when a new report shows most Arizona classrooms do not have a high enough vaccination rates to prevent an outbreak of measles; Banner MD Anderson in Phoenix is now offering a groundbreaking therapy for melanoma patients; Harry Mitchell, a former Tempe mayor and U.S. congressman, has died at 86
Problems playing video? | Closed Captioning Feedback
Where to Watch Arizona Horizon
Arizona Horizon is available to stream on pbs.org and the PBS app.
Providing Support for PBS.org
Learn Moreabout PBS online sponsorship>> COMING UP NEXT ON ARIZONA HORIZON.
MORE ON AN EXECUTIVE ORDER.
ALSO, TONIGHT, NEW SKIN CANCER TREATMENT OFFERS GROUNDBREAKING THERAPY FOR MEL NA NOMA PATIENTS AND REMEMBER THE LEGACY OF THE FORMER MAYOR OF TEMPE.
>> ARIZONA HORIZON IS MADE POSSIBLE BY THE FRIENDS OF ARIZONA PBS, MEMBERS OF THE PUBLIC TELEVISION STATION.
>> GOOD EVENING, WELCOME.
>> I AM STEVE GOLDSTEIN FILLING IN FOR TED SIMONS.
EARLIER THIS WEEK, PRESIDENT TRUMP SIGNED AN EXECUTIVE ORDER.
THE ORDER COMES AS ARIZONA SCHOOLS ARE ALREADY REPORTING VACCINATION RATES THAT FALL BELOW THE RECOMMEND LEVELS.
FOR MORE, WE WELCOME BILL HUMBLE.
WELCOME BACK, WILL.
>> HI, STEVE.
I WANT TO DIG TO THE EXECUTIVE ORDER.
DO YOU SEE THIS AS AN IMMEDIATE THREAT TO PEOPLE IN COMMUNITIES WHO DON'T WANT TO SEE ANY CHANGES TO VACCINATION SCHEDULES, ANYTHING?
>> HOW DIRE KITE BE FOR FOL BE WHO WANT TO KEEP THE SYSTEM AS SPICING THIS EXECUTIVE OVER IS NOT TIRE.
THERE IS OTHER THING THIS IS THE SECRETARY WANTS TO ACCOMPLISH, TO.
HE IS WORKING THROUGH THOSE.
IF WE HAVE TIME, HE CAN TALK ABOUT THAT.
MY VIEW IS NOT GLOOM AND DOOM OR THE END OF THE WORLD OR ANYTHING LIKE THAT.
A LOT OF IT, IN MY VIEW, A LOT OF IT IS PERFORMATIVE.
WE GET TO SOME OF THAT.
>> PREVIOUSLY, THOUGH.
PERFORMATIVE DOES HAVE IMPACT ON PEOPLE'S EMOTIONS.
>> YES.
OF ALL THE THINGS THAT IS IN THAT EXECUTIVE ORDER.
THE ONE PITA HAS AN IMPACT, I THINK, IS NOT THE POLICY PIECES THAT WAS IN THAT EO.
EXECUTIVE ORDER.
IT WAS THE THEME THE SECRETARY KENNEDY, NOW THE PRESIDENT ARE PROMOTING THAT, VACCINES ARE SOME, THESE ARE VERY MUCH TESTED VACCINES THAT ARE PROVEN TO BE SAFE AND EFFECTIVE.
THAT THEME THAT THESE ARE IN SOME WAY ARE UNSAFE OR UNWISE.
>> WELL, THAT IS THE PROBLEM.
>> YEAH.
LET'S TAKE TO MR.
WHAT STRUCK ME IN READING A BLOG POST YOU PIT TOGETHER.
THE IDEA OF SEPARATING THE MEASLES, MUMPS, RUBELLA, INTO TWO SEPARATE THINGS.
FIRST OF ALL.
LET'S SAY THAT WERE TO MOVE FORWARD.
WOULD THAT BE INCREDIBLY INEFFECTIVE.
COULD IT BE VIABLE?
COULD IT BE DONE BY THE MAKERS, THE SYSTEMS HAVING TO PUT IT TOGETHER?
>> FIRST 6 ALL.
IT IS NOT FOOD.
IT IS NOT GOING TO HAPPEN.
LET'S PUT THAT TO REST.
IT IS NOT GOING TO HAPPEN.
NO VACCINE, BY THE WAY, THERE IS MMR, THERE IS ANOTHER ONE, MMR WHICH IS CHICKENPOX IN IT.
THERE IS NO LICENSED INDIVIDUAL MEASLES VACCINE, MUMPS VACCINE, RUBELLA, THE LAST LICENSE ENDED IN 2090 BECAUSE NO ONE WAS BUYING IT.
NO ONE WANTED TO GIVE THE KID THREE SHOTS WHEN THEY COULD GIVE THE KID ONE, SO LIKE THAT VACCINE, SO IF A RACK SEEN MANUFACTURER, LET'S SAY, OH, OK, HERE IS THE EO.
LET'S PUT A WHOLE BUNCH OF THE RESEARCH, DEVELOPMENT MONEY INTO BUILDING A NEW VACCINE THAT NO ONE IS GOING TO BUY, GO THROUGH THE CLINICAL TRIALS THAT WON'T BE OVER UNTIL THE ADMINISTRATION IS LONG GONE.
IT IS NOT GOING TO HAPPEN.
>> IT IS ALMOST A POLITICAL QUESTION.
FORGIVE ME.
WHAT IS THE POINT OF THIS THEN.
IT IS THIS TO KEEP PEOPLE PUMPED UP.
ASKING THESE QUESTIONS BECAUSE, I DON'T WANT TO SPEAK FOR EVERYONE, BUT IT SEEMS LIKE, FOR MOST PEOPLE, THE CONNECTION TO AUTISM WAS NOT PROVEN TO BE REAL AND YET THAT IS STILL IN RFK'S WHEELHOUSE, ISN'T IT?
>> IT HAS BEEN PROVEN.
>> RIGHT.
>> THERE HAS BEEN STUDIES OVER THE LAST 20 YEARS IN OVER 5 MILLION KIDS THAT THEY FOL LO HEED IN SEVEN COUNTRIES, UM, IN MULTIPLE STUDIES PER REVIEWED STUDIES AND, AND STUDIES OF STUDIES, SYSTEMIC REVIEWS, THEY ARE CALLED.
ALL OF THAT SHOWS THERE IS NO LINK.
>> WELL, SO, WHY ARE WE STILL HEARING THIS INTO WHY?
>> I WAS EVEN THINKING ABOUT SENATOR CASSIDY, WHO RECENTLY WAS LEAVING OFFICE.
HE WAS ONE WHO CAST, BASICALLY, THE DECIDING VOTE TO MAKE RFK THE SECRETARY THEN HE REGRETTED IT IMMEDIATELY AND TOLD ME WOULD BE DIFFERENT ABOUT VACCINES.
>> HE TRUSTED HIM.
HE VOTED FOR HIM ANYWAY.
I HAVE SEEN HIS TWEETS AND STUFF.
OH, YEAH.
THIS IS NOT WHAT I THOUGHT.
WELL, KENNEDY HAS HAD A TRACK RECORD FOR MANY MANY YEARS.
I MEAN, HE MADE A LIVING CHALLENGING VACCINE SAFETY.
SUING MANUFACTURERS AND STUFF.
SO THIS WAS EASY TO PREDICT.
>> YOU ASKED WHAT IS THE POINT?
>> RIGHT.
>> YOU ARE ASKING THE WRONG GUY.
YOU HAVE TO ASK WHAT IS IN WASHINGTON.
LIKE WHO IS ADVISING ALL OF THOSE PEOPLE THAT THIS WAS A WISE THING TO DO?
THEY MUST THINK THERE IS SOME POLITICAL VALUE TO IT.
>> YEAH.
BECAUSE NONE OF THE THINGS IN THE EXECUTIVE ORDER ARE GOING TO ACTUALLY HAPPEN.
>> SO LET'S DIG.
WE GOT A COUPLE MORE MINUTES LEFT.
I WANT TO DIG MORE INTO WHAT STOOD OUT TO YOU.
WHAT CONCERNS YOU, NOT NECESSARILY NOW.
JUST PERFORMATIVE.
AS THE YEARS GO FORWARD.
IT IS THIS STATE SITTING THE STAGE FOR SOMETHING?
>> YEAH.
I AM GLAD YOU ASKED ABOUT THAT.
SO LAST YEAR, SECRETARY KENNEDY GOT RID OF WHAT IS CALLED THE ADVISORY COMMITTEE FOR IM MY NATION PRACTICES.
THAT IS A GROUP OF ADVISERS, TECHNICAL PEOPLE, SCIENTISTS, VACCINE SCIENTISTS AND OTHER MD'S, THAT EXAMINE THE DATA AND THEY PUT FORWARD THE VACCINE RECOMMENDATIONS, THAT COMMITTEE'S RECOMMENDATIONS ARE HARD WIRED TO INSURANCE, SO YOUR COMMERCIAL HEALTH INSURANCE THAT YOU HAVE.
IF YOU HAVE ACCESS AS YOUR HEALTH INSURANCE.
NO MATTER WHAT THE HEALTH INSURANCE IS THIS.
THEY USE THE ADVISORY COMMITTEE FOR IMMUNIZATION PRACTICES RECOMMENDATIONS SO WHAT KENNEDY KNOWS, THAT IS THE LINCHPIN.
IF HE WANTS TO GET VIEWER RACK SCENES OUT THERE.
THE THING HE NEEDS TO DO IS GET RID OF THE ADVISORY COMMITTEE SO HE REMOVED THE ENTIRE VACCINE COMMITTEE AND PUT THE OWN PEOPLE IN, THAT HE KNEW WERE ANTI-VAX, THANKFULLY, WE STILL HAVE CHECKS AND BALANCES IN THE JUDICIAL BRANCH, THEY SAID, HOLD ON, YOU DIDN'T FOLLOW PROPER PROCESSES, PLUS THESE GUYS, AND WOMEN, ARE NOT QUALIFIED, SO THE RISK IS, THAT ULTIMATELY, IN THROUGH THE COURT SYSTEM, IT IS IN THE FIRST DISTRICT COURT RIGHT NOW.
THAT EVENTUALLY, IT IS GOING TO GET TO THE U.S.
SUPREME COURT, WHO IS GOING TO VAL ADULT, THAT KENNEDY DID THIS STUFF RIGHT.
AND THAT, THAT, OK, WHICH WOULDN'T HAPPEN FOR AT LEAST 18 MONTHS, THAT IS THE REAL RISK TO CHILDHOOD VACCINES BECAUSE IT WILL UNDERCULT.
IT WON'T GET RID OF THE VACCINE, THEY WILL BE LICENSED BUT PEOPLE END UP HAVING TO PAY CASH FOR IT INSTEAD OF INSURANCE.
WE HAVE 30 SECONDS LEFT, WILL.
SO HOW ARE IMMUNIZATION RATES DOING RIGHT NOW IN ARIZONA AS WE START THE SCHOOL YEAR?
DEPENDS ON THE PART OF THE STATE YOU ARE IN.
OVERALL, 88% FOR MEASLES WHICH IS NOT ENOUGH.
PENA COUNTY IS GREAT.
THEY HAVE IMMUNITY.
SANTA CRUZ COUNTY, THEY ARE GREAT.
MOST OF HELA, MOJAVE COUNTIES THE VACCINATION RATES ARE TERRIBLE.
>> OK.
IT DEPENDS WHERE ON YOU LIVE.
OK.
THANKS FOR BEING HERE.
>> MY PLEASURE.
♪ ♪ BANNER MD ANDERSON IN PHOENIX IS OFFERING A GROUNDBREAKING THERAPY FOR MELANOMA PATIENTS.
THEY ARE 40% HIGHER THAN THE U.S.
AVERAGE.
FOR MORE, THE DOCTOR IS HERE FROM BANNER MD ANDERSON.
DOCTOR, THANKS FOR BEING HERE.
>> THANK YOU.
GLAD TO BE HERE.
>> LET'S TALK ABOUT TIL THERAPY IS.
CAN YOU DESCRIBE IT FOR US AND WHAT IT CAN DO?
>> YEAH.
OF COURSE, IT IS A NEW IMMUNOTHERAPY, CELL THERAPY, THAT REUSE RECENTLY.
IT IS NOT COME LEALLY NEW.
WE HAVE BEEN USING IT AND LEUKEMIAS SINCE 2019 OR 2019 WHERE THE FIRST APPROVAL HAPPENED IN LYMPHOMA.
NOW WE GET CELL THERAPY IS THE FIRST CELL THERAPY APPROVED FROM MELANOMA THAT HAPPENED IN FEBRUARY OF 20.
THE IDEA OF THERAPY OR CELL THERAPY IN GENERAL THAT WE USE IN PATIENT WHERE WE SEND THEM TO THE LAB, WE GROW THEM.
WE STIMULATE THEM.
WE GIVE THEM IMMUNE THERAPY IN THE LAB IN THE PROCESS THAT TAKES 3 TO 4 BEAKS TO FINISH THEN WE GO TO BILLIONS OF CELLS.
WE ADMINISTER THEM BACK TO THE PATIENTS NOW THEY ARE STRONGER, SMARTER, THEY CAN KILL THE CANCER CELLS WHICH IS THEIR JOB ORDERLY TO DO.
>> SO WHO IS A GOOD CANDIDATE.
>> SO THERAPY NOW, WHICH IS LIFE IS APPROVED FOR MELA THEM INTO SO THAT IS PATIENTS WITH STAGE FOUR MELANOMA WHO FAILED THE FIRST LINE OF THERAPY OR THE FIRST LINE OF THERAPY.
MAINLY, WE HAVE TWO MAIN TREATMENTS OR TWO GOOD TREATMENTS.
A GROUP OF OR CLASS POINTS INHIBITORS WHERE THEY REMOVE THE BRAKES ON IMMUNE CELLS AND SPARK THE IMMUNE THERAPY REUSE.
THE OTHER TREATMENT IS INHIBITOR.
THAT IS TARGETED THERAPY IF PATIENTS FAIL THOUGH TWO TREATMENT HIMSELFS THEN THERE IS REALLY NO OTHER TREATMENT FOR MELA THEM INTO.
THAT IS WHERE CELL THERAPY COMES INTO PLAY AND PROVIDES HOPE FOR OUR PATIENTS.
DO YOU HAVE A NUMBER AT THIS POINT OF FOL BEES WHO HAVE BEEN TREATED?
WHAT THE SUCCESS RATE SAYS NO SO WE START, WE LAUNCHED THE PROGRAM IN JULY OF LAST YEAR OF 2025, SO FAR, WE ENROLLED AROUND 20 PATIENTS ON THIS PROGRAM.
THAT IS JUST IN OUR FACILITY.
WE ARE SEEN A LOT OF GOOD RESULTS AS WE EXPECT, BECAUSE WHAT WE LEARNED FROM THE TRIAL, THAT LED TO THE APPROVAL OF THE PER PI, THAT IS THE RESPONSE IS AROUND 30 TO 40%, SOB THIS IS PROVIDING 30 TO 40% OF PATIENTS WHO HAVE ANY OTHER TREATMENTS EVER.
>> NOT ONLY THAT, THE DISEASE CONTROL RATE, SO THE 30 TO 40% THE PATIENT WHO RESPONDS EFFICIENTLY FOR THE FDA APPROVAL, BUT THERE ARE PATIENTS WHO GET THE DISEASE UNDER CONTROL, BUT THEY DON'T APPLY FOR THAT.
THAT IS UP TO 60-70%.
SO WE ARE HOPE HELPING MORE THAN HALF OF THE PATIENTS WITH STAGE 4 MELANOMA.
THEY DIDN'T HAVE ANY GOOD TREATMENT OPTIONS BEFORE.
>> AND AS I MENTIONED IN THE INTRODUCTION.
THIS IS A PLACE BECAUSE I PRESUME BECAUSE OF HOW MUCH SUN WE HAVE.
HOW MUCH SUN EX EXPOSURE.
THIS IS OBVIOUSLY A GREAT PLACE TO DO THIS KIND OF RESEARCH, TO HAVE A MAJOR IMPACT.
>> 100.
I JUST MOVED FROM PITTSBURGH LAST YEAR.
AND I CAN TELL THE TEF REPS BETWEEN HOW MANY WE HAVE HERE COMPARED TO THE AREAS WHERE IT IS LESS SUN EXPOSURE.
>> LET ME ASK A REAL LAY PERSON'S QUESTION.
CAN YOU REZ MIND PEOPLE WHO HEARD OF MELANOMA AND CARCINOMA.
WHAT DOES MELA THEM INTO, RATHER STAGE FOUR OR NOT.
WHAT STANDS OUT IN THE WHAT EFFECT DOES IT HAVE ON PEOPLE'S SKIN OR THE REST OF THEM?
WELL, WHAT IS IMPORTANT IN MELANOMA.
IF ANYONE HAS A MOLE THAT IS THERE FOR MANY YEARS THEN YOU START SEEING CHANGES IN THE MOLE FROM SIZE, COLOR, STRUCTURE, ANYTHING, IT NEEDS TO BE CHECKED.
THAT IS HOW WE DO IT.
THAT IS HOW IT STARTS.
AND THEN, LIMP NODES CAN BE A SIGN, SWOLLEN LIMP NODES, MELA PEOPLE IN NA IS A COMMON SITE IN THE NECK, ARMPIT, GROIN WHERE ARE.
MAINLY, ANY CHANGES IN SKIN LESIONS EVEN IF PEOPLE HAVE IT FOR MANY YEARS.
THIS IS SOMETHING THAT IS MORE LIKELY, I ASK THIS AS SOMEONE WHO IS FAIR SKINNED, MORE LIKELY THAT SOMEONE WHO LOOKS LIKE ME WOULD HAVE IT OR ANYONE WHO HAS HAD A LOT OF SUN.
>> 100%.
IT IS MORE COMMON IN PEOPLE ACTUALLY.
SHOULD I CALL MY PAR SHENS.
>> WE ONLY GOT A MINUTE OR SO LEFT.
WHAT ARE THINGS PROMISING DOPES?
WHAT ARE YOU LOOKING FORWARD TO KNOW, TO GET MORE THAN 20 PATIENTS AND WHAT NOT?
WHAT ARE YOU LOOKING FOR?
WHAT ARE YOU OPT MISS TICK ABOUT INTO SO WE ARE LOOKING INTO PROVIDING THE THERAPY TO AS MANY PATIENTS AS THEY NEEDED IT RIGHT.
SO WE ARE LOOK WHERE I TO VELT JUST IN THE VALLEY AREA TO PROVIDE IT ALL.
PATIENTS WHO DO VNT, THEY DON'T NEED TO TRAVEL SOMEWHERE ELSE.
BUT OTHER THING, ALSO, WE ARE LOOKING FOR, THE ONGOING RESEARCH IS TO IMPROVE THE TECHNOLOGY.
THIS IS 30-40% NUMBER I MENTIONED.
50-60-70 HOPLY 100 BEING HELD IN THE FUTURE.
THANKS MUCH.
GOOD LUCK.
THANK YOU.
>> THANK YOU.
♪ ♪ >> THE MAYOR OF TEMPE WHOSE PUBLIC SERVICE SPANNED FOUR DECADES.
I DIED TWO WEEKS AGO AT THE AGE OF 86.
HE WAS A TEACHER AND COACH AT TEMPES HIGH AND 8 YEARS THEN ARIZONA SENATE, 4 YEARS REPRESENTING CONGRESS.
TO HONOR HIM, SHARE MORE ABOUT THE LEG TY, WE WELCOME THE VICE MAYOR OF TEMPE.
>> THANK YOU FOR INVITING ME.
>> YOU SO YOU KNOW MUCH BELT BETTER THAN I TO.
I RECALL THE SMILE VERY WELL.
>> WAS THERE SOMEONE BEHIND IT.
IS HE LOOK THE NICE TEACHER KIND OF GUY?
>> ALL OF THAT.
AUM OF THAT.
ALL OF IT IS TRUE.
THE SMILE WAS ALWAYS CURIOSITY AND INTEREST.
IT IS INTERESTING THAT YOU BRING THAT UP, BECAUSE THAT IS HOW REMEMBER HARRY, HE ALWAYS HAD A LOOK, LIKE, OH, HE IS ABOUT TO ASK YOU A QUESTION.
OR TELL YOU A STORY, THAT WAS HARRY.
>> I DIDN'T WANT TO PAINT TOO BROAD OF A BRUSH WHEN WE TALK ABOUT PEOPLE IN ELECTED OFFICE.
THE FACT HE HAD THE YEARS AS A TEACHER.
THE FABLE IT WAS IN TEMPE, HE OBVIOUSLY HAD A SPECIAL AFFINITY FOR THE CITY OF TEM?
HE A HARRY HAD A SPECIAL AFUN TY FOR PEOPLE.
WHETHER HE WAS IN AN ELECTED ROLE, WHETHER IN CONGRESS, AT THE STATE HOUSE OR ON CITY COUNCIL AS MAYOR, HE WAS ALWAYS A TEACHER.
AND HARRY ALWAYS HAD STORIES ABOUT HIS STUDENT STUS AND HE WOULD SAY, OH, SO AND SO WAS IN MY CLASS, AND HERE IS A FACT ABOUT THEIR FAMILY.
HE NOT TO KNOW PEOPLE.
>> SO I LOVE THE FACT, IF YOU CAN REMEMBER THIS FOR US.
THIS WOULD BE A FUN EXPERIENCE WHEN YOU TALK ABOUT.
WHEN YOU WERE IN HIGH SCHOOL YOURSELF.
>> YEAH.
YOU WENT ON A TRIP TO SAN ANTONIO.
>> OH-OH.
TO GET TEMPE DESIGNATED ALL AMERICAN CITY.
>> IT WAS, IT WAS WHEN TEMPE HAD APPLIED FOR THE FIRST ALL AMERICA CITY AWARD.
I HAD SERVED ON THE ADVISORY COME MISSION.
>> OK.
>> APPOINTED BY HARRY MILT CHEL AND WE WENT TO PRESENT TO THE FINAL JURY FOR THE AWARD.
OOP OK.
>> VERY IMPOSING PRESENTATION BY FORMER GOVERNOR HOWARD PILE, A WONDERFUL RADIO VOICE, VERY GREAT CREDIBLE AND ON THE APPLICATION, FOR THE AWARD WAS THE MAYOR'S ADVISORY COMMISSION, WHICH WAS PRETTY NEW, ONLY A FEW YEARS OLD, AND SO, AT THE END OF A FANTASTIC PRESENTATION, THEY WERE TRYING TO FIND A QUESTION, SO THEY SAID, OK.
WHAT ABOUT THIS YOUTH COMMISSION?
I AM WONDERING THEIR WE, THINK, WAS BASED ON IS THIS REAL?
IT DID HAVE THE SAME STATURE AS THE ADULT COMMISSIONS WHICH IT DID?
AND SO THEY SHUFFLED ME UP TO THE FRONT, AND A VERY IMPOSING JURY, AND THEY SAID, SO, HOW OFTEN DID YOU GET TO SEE THE MAYOR?
AND I SAID, AND KNOWING HARRY, PEOPLE WHO KNOW HARRY KNOW THIS IS TRUE.
I BLURTED, I WAS NOT, IT WAS NOT A DIGNIFIED STANCE, I BLURTED OUT, ANY TIME WE WANT TO?
HE WOULD ALWAYS APPEAR BECAUSE OF WHO WE WERE.
HE WAS ALWAYS ESPECIALLY INTERESTED.
HE SPOKE WITH EACH ONE OF US INDIVIDUALLY AND HE WAS WONDERFUL.
DID HE RETAIN THAT THROUGHOUT THE REST OF HIS LIFE LIFE AND CAREER?
HE WAS ALWAYS AVAILABLE AS FOLKS WHO WANTED TO TRY SOMETHING?
>> HE WAS ALWAYS WILLING TO TALK.
ALWAYS WILLING TO TALK TO ANYONE?
>> SO I THINK, WHEN PEOPLE HEAR SOME OF THESE THINGS, THEY MAY HAVE FORGOTTEN THE TERPS IN CONGRESS.
I AM NOT SURE HE WOULD.
HE IS ASSOCIATED WITH TEMPE.
IN ANYWAY WERE YOU SURPRISED I ENDED UP GOING TO WASHINGTON, BECAUSE WE TALK ABOUT HOW LOCAL POLITICIANS OR ELECTED OFFICIALS TEND TO RETAIN THE LOVE OF O'KON STITIAL TENTS ONCE YOU GO TO WASHINGTON, NOT SO MUCH.
I THINK HARRY RETAINED THE LOVE OF THE CONSTITUENTS WHEREVER HE WAS.
AND I BELIEVE I SPEAK FOR A LOT OF PEOPLE WHEN HE WAS ELECTED TO CONGRESS, WE WERE THRILLED.
IT WAS THE QUINTESSENTIAL STORY OF MR.
SMITH GOES TO WASHINGTON.
WE WERE SO EXCITED ABOUT HISTORY, COME ALIVE FOR HARRY, RIGHT?
WOULD VERY STUDIED, TAUGHT ALL HIS LIFE, HE GETS TO NOW GO EXPERIENCE IT FIRST HAND.
SO FOR ALL OF US, IT IS HARRY WHAT STORIES DO YOU HAVE FOR US?
>> TELL US MORE.
>> SO, I HAVE TO ASK KIND OF A LEGACY QUESTION.
>> SURE.
A BECAUSE TO SOME EXTENT WE TALKED ABOUT WHAT A GREAT PART OF THE LEGSY WOULD BE.
I WONDER IF YOU COULD SORT OF, IN ADDITION TO THE PERSONALITY, THE WONDERFUL CURIOSITY.
IT IS THERE SOMETHING THAT PEOPLE WHO LIVE IN TEMPE, THOSE WHO DON'T SHOULD KNOW ABOUT TEMPE.
ARE THERE A COUPLE OF IN THES THAT WILL BE THERE FOREVER OR ALMOST FOREVER THAT REALLY ONLY HAPPEN BECAUSE OF IM HIM?
>> HARRY DIDN'T INFLUENCE TEMPE.
HE SHAPED TEMPE.
HE WAS ONE ONE OF THE GREAT ART TECHS OF TEMPE.
SO GEOGRAPHICALLY, THERE ARE MANY PROJECTS THAT HE INFLUENCED MILL AVENUE, TEMPES TOWN LIKE.
BUT IT IS ALSO HOW WE INTERACT WITH ONE ANOTHER AND HOW THE STORY OF IF YOU ARE A TEMPE, WE ARE SEPARATED BY THREE DEGREES OF SEPARATION.
IT IS THE CULTURE THAT HE HELPED BUILD.
>> WAS HARRY MITER, I HAVE TO ASK IT.
I WAS GREAT GUY.
DID HE IN SOME WAY TRANSCEND PART SEASONSHIP TO WHATEVER.
I KNOW HE RAN AS A DEMOCRAT.
HE WON AS A DEMOCRAT IN CONGRESS.
WAS HE SOMEONE WHO COULD THREAT THREAD THE NEEDLE ON THAT?
>> ABSOLUTELY.
I THINK HISTORY WILL ANALYZE THAT FOR YOU.
HARRY REPRESENTED PEOPLE, INDIVIDUALS.
>> SO DOWN TO A MINUTE OR SO LEFT.
>> WHAT IS ONE MEMORY OF HARRY MITCHELL THAT ONLY ARLENE COULD TELL US ABOUT?
>> WELL, I THINK I SHARE THIS WITH SO MANY PEOPLE WHO HAVE ADMIRED HIM, BEEN INFLUENCED BY HIM.
JUST THAT SMILE, GETTING TO KNOW EVERYONE, AND APPRECIATING EVERYONE AND IN THEIR OWN STORY.
>> AND HE IS SOMEONE WHOSE LEGACY WILL LIVE ON?
I SURE HOPE SO.
OK.
ARLENE, THANKS FOR BEING HERE.
THATTEN.
YOU THAT IS ALL FOR THIS EDITION OF ARIZONA HORIZON.
I AM STEVE GOLDSTEIN IN FOR TED SIMONS.
THANKS SO MUCH FOR WATCHING.
♪ ♪ ♪ ♪ ♪
New Episode- News and Public Affairs
Top journalists deliver compelling original analysis of the hour's headlines.
New Episode- News and Public Affairs
Today's top journalists discuss Washington's current political events and public affairs.
New Episode
New Episode
New Episode
New Episode
New Episode
New Episode
Support for PBS provided by:
Arizona Horizon is a local public television program presented by Arizona PBS